Chemotherapy for eye cancer

Matthew Wilson, Grazyna Czechonska, Paul T. Finger, Aaron Rausen, Mary E. Hooper, Barrett G. Haik

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Chemotherapy has been used to treat a multitude of eye cancers. We attempted to review the role of chemotherapy in the treatment of ocular, adnexal, and orbital malignancies by conducting an extensive search of the medical literature. Unfortunately, the published reports typically contain few patients with limited follow-up, precluding definitive recommendations. For most eye cancers, multicenter trials will offer the potential to gather the numbers of patients required to determine the clinical utility of chemotherapy.

Original languageEnglish (US)
Pages (from-to)416-444
Number of pages29
JournalSurvey of Ophthalmology
Volume45
Issue number5
DOIs
StatePublished - Jan 1 2001

Fingerprint

Eye Neoplasms
Drug Therapy
Multicenter Studies
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Wilson, M., Czechonska, G., Finger, P. T., Rausen, A., Hooper, M. E., & Haik, B. G. (2001). Chemotherapy for eye cancer. Survey of Ophthalmology, 45(5), 416-444. https://doi.org/10.1016/S0039-6257(00)00210-1

Chemotherapy for eye cancer. / Wilson, Matthew; Czechonska, Grazyna; Finger, Paul T.; Rausen, Aaron; Hooper, Mary E.; Haik, Barrett G.

In: Survey of Ophthalmology, Vol. 45, No. 5, 01.01.2001, p. 416-444.

Research output: Contribution to journalArticle

Wilson, M, Czechonska, G, Finger, PT, Rausen, A, Hooper, ME & Haik, BG 2001, 'Chemotherapy for eye cancer', Survey of Ophthalmology, vol. 45, no. 5, pp. 416-444. https://doi.org/10.1016/S0039-6257(00)00210-1
Wilson M, Czechonska G, Finger PT, Rausen A, Hooper ME, Haik BG. Chemotherapy for eye cancer. Survey of Ophthalmology. 2001 Jan 1;45(5):416-444. https://doi.org/10.1016/S0039-6257(00)00210-1
Wilson, Matthew ; Czechonska, Grazyna ; Finger, Paul T. ; Rausen, Aaron ; Hooper, Mary E. ; Haik, Barrett G. / Chemotherapy for eye cancer. In: Survey of Ophthalmology. 2001 ; Vol. 45, No. 5. pp. 416-444.
@article{82fcf87a20424e1dbf25e114039ffb25,
title = "Chemotherapy for eye cancer",
abstract = "Chemotherapy has been used to treat a multitude of eye cancers. We attempted to review the role of chemotherapy in the treatment of ocular, adnexal, and orbital malignancies by conducting an extensive search of the medical literature. Unfortunately, the published reports typically contain few patients with limited follow-up, precluding definitive recommendations. For most eye cancers, multicenter trials will offer the potential to gather the numbers of patients required to determine the clinical utility of chemotherapy.",
author = "Matthew Wilson and Grazyna Czechonska and Finger, {Paul T.} and Aaron Rausen and Hooper, {Mary E.} and Haik, {Barrett G.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0039-6257(00)00210-1",
language = "English (US)",
volume = "45",
pages = "416--444",
journal = "Survey of Ophthalmology",
issn = "0039-6257",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Chemotherapy for eye cancer

AU - Wilson, Matthew

AU - Czechonska, Grazyna

AU - Finger, Paul T.

AU - Rausen, Aaron

AU - Hooper, Mary E.

AU - Haik, Barrett G.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Chemotherapy has been used to treat a multitude of eye cancers. We attempted to review the role of chemotherapy in the treatment of ocular, adnexal, and orbital malignancies by conducting an extensive search of the medical literature. Unfortunately, the published reports typically contain few patients with limited follow-up, precluding definitive recommendations. For most eye cancers, multicenter trials will offer the potential to gather the numbers of patients required to determine the clinical utility of chemotherapy.

AB - Chemotherapy has been used to treat a multitude of eye cancers. We attempted to review the role of chemotherapy in the treatment of ocular, adnexal, and orbital malignancies by conducting an extensive search of the medical literature. Unfortunately, the published reports typically contain few patients with limited follow-up, precluding definitive recommendations. For most eye cancers, multicenter trials will offer the potential to gather the numbers of patients required to determine the clinical utility of chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0035077530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035077530&partnerID=8YFLogxK

U2 - 10.1016/S0039-6257(00)00210-1

DO - 10.1016/S0039-6257(00)00210-1

M3 - Article

VL - 45

SP - 416

EP - 444

JO - Survey of Ophthalmology

JF - Survey of Ophthalmology

SN - 0039-6257

IS - 5

ER -